Evidence map›Paper›PMID 34680581›Full record

ArticleBiomedicines2021

Evaluation of a Murine Model for Testing Antimicrobial Implant Materials in the Blood Circulation System.

Caroline Moerke, Marlen Kloss, Katharina Wulf, Sabine Illner, Sabine Kischkel, Martina Sombetzki, Niels Grabow, Emil Reisinger, Alper Öner, Hüseyin Ince

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Novel dalbavancin-PLLA implant coating prevents hematogenousFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Caroline MoerkeDepartment of Cardiology, University Medical Center Rostock, 18057 Rostock, Germany.
Marlen KlossDivision of Tropical Medicine and Infectious Diseases, University Medical Center Rostock, 18057 Rostock, Germany.
Katharina WulfInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.ORCID 0000-0002-9891-5174
Sabine IllnerInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.ORCID 0000-0002-2033-2964
Sabine KischkelInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.ORCID 0000-0002-5018-3920
Martina SombetzkiDivision of Tropical Medicine and Infectious Diseases, University Medical Center Rostock, 18057 Rostock, Germany.
Niels GrabowInstitute for Biomedical Engineering, University Medical Center Rostock, 18119 Rostock, Germany.
Emil ReisingerDivision of Tropical Medicine and Infectious Diseases, University Medical Center Rostock, 18057 Rostock, Germany.
Alper ÖnerDepartment of Cardiology, University Medical Center Rostock, 18057 Rostock, Germany.
Hüseyin InceDepartment of Cardiology, University Medical Center Rostock, 18057 Rostock, Germany.
University of Rostock · DE

Funding

Bundesministerium für Bildung und Forschung RESPONSE "Partnership for Innovation in Implant Technology"European Social Fund ESF/14-BMA55-0037/16
6 · The paper itself

Abstract

Medical device-related infections are becoming a steadily increasing challenge for the health care system regarding the difficulties in the clinical treatment. In particular, cardiovascular implant infections, catheter-related infections, as well as infective endocarditis are associated with high morbidity and mortality risks for the patients. Antimicrobial materials may help to prevent medical device-associated infections and supplement the currently available therapies. In this study, we present an easy-to-handle and simplified in vivo model to test antimicrobial materials in the bloodstream of mice. The model system is composed of the implantation of a bacteria-laden micro-stent scaffold into the murine tail vein. Our model enables the simulation of catheter-related infections as well as the development of infective endocarditis specific pathologies in combination with material testing. Furthermore, this in vivo model can cover two phases of the biofilm formation, including both the local tissue response to the bacterial biofilm and the systemic inflammatory response against circulating bacteria in the bloodstream that detached from a mature biofilm.

Indexed as

antimicrobialbloodstream infectioncardiovascular biomaterialcatheter-related infectionsinfective endocarditisin vivo

Identifiers

PMID34680581
PMCPMC8533524
OpenAlexW3207625138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.